Ironwood Pharmaceuticals PE Ratio 2009-2020 | IRWD

Current and historical p/e ratio for Ironwood Pharmaceuticals (IRWD) from 2009 to 2020. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Ironwood Pharmaceuticals PE ratio as of July 02, 2020 is 12.41.
Ironwood Pharmaceuticals PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-07-02 10.18 19.21
2020-03-31 10.09 $0.53 19.04
2019-12-31 13.31 $0.13 102.38
2019-09-30 8.59 $-0.27 0.00
2019-06-30 10.94 $-1.54 0.00
2019-03-31 13.53 $-1.94 0.00
2018-12-31 10.36 $-1.85 0.00
2018-09-30 18.46 $-1.67 0.00
2018-06-30 19.12 $-0.75 0.00
2018-03-31 15.43 $-0.73 0.00
2017-12-31 14.99 $-0.80 0.00
2017-09-30 15.77 $-0.97 0.00
2017-06-30 18.88 $-0.98 0.00
2017-03-31 17.06 $-0.83 0.00
2016-12-31 15.29 $-0.56 0.00
2016-09-30 15.88 $-0.56 0.00
2016-06-30 13.08 $-0.66 0.00
2016-03-31 10.94 $-0.85 0.00
2015-12-31 11.59 $-1.00 0.00
2015-09-30 10.41 $-1.18 0.00
2015-06-30 12.06 $-1.15 0.00
2015-03-31 16.00 $-1.25 0.00
2014-12-31 15.32 $-1.39 0.00
2014-09-30 12.96 $-1.55 0.00
2014-06-30 15.33 $-1.76 0.00
2014-03-31 12.32 $-1.89 0.00
2013-12-31 11.61 $-2.38 0.00
2013-09-30 11.84 $-2.36 0.00
2013-06-30 9.93 $-1.43 0.00
2013-03-31 18.29 $-1.24 0.00
2012-12-31 11.08 $-0.71 0.00
2012-09-30 12.78 $-0.37 0.00
2012-06-30 13.78 $-1.00 0.00
2012-03-31 13.31 $-0.81 0.00
2011-12-31 11.97 $-0.66 0.00
2011-09-30 10.80 $-0.71 0.00
2011-06-30 15.72 $-0.58 0.00
2011-03-31 13.98 $-0.57 0.00
2010-12-31 10.35 $-0.63 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.622B $0.428B
Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company that discovers, develops, and intends to commercialize innovative human medicines. The Company's first in class compound, Linaclotide, is being evaluated in a confirmatory Phase 3 program for the treatment of irritable bowel syndrome with constipation and chronic constipation. The Company also focuses on one Phase 1 pain drug candidate and multiple preclinical programs, as well as on building a specialty biochemicals business based on a proprietary strain-development platform. Ironwood also has a growing pipeline of additional drug candidates in earlier stages of development. Ironwood is headquartered in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $65.380B 37.10
Takeda Pharmaceutical (TAK) Japan $56.087B 9.83
Astellas Pharma (ALPMY) Japan $30.738B 15.58
Eisai (ESALY) Japan $23.358B 20.25
UCB SA (UCBJF) Belgium $22.796B 0.00
Merck (MKGAF) Germany $15.419B 20.22
Grifols, S.A (GRFS) Spain $12.857B 15.98
Neurocrine Biosciences (NBIX) United States $11.643B 53.81
Catalent (CTLT) United States $11.267B 43.56
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 0.00
Ionis Pharmaceuticals (IONS) United States $8.469B 45.03
IPSEN SA ADR (IPSEY) France $7.049B 0.00
Orion OYJ (ORINY) Finland $6.766B 30.32
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.664B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.074B 9.72
United Therapeutics (UTHR) United States $5.296B 10.04
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $4.498B 491.11
Nektar Therapeutics (NKTR) United States $4.186B 0.00
Evotec AG (EVTCY) Germany $4.100B 110.61
FibroGen (FGEN) United States $3.876B 0.00
Hypermarcas (HYPMY) Brazil $3.819B 11.62
ChemoCentryx (CCXI) United States $3.588B 0.00
PTC Therapeutics (PTCT) United States $3.470B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.581B 10.60
Sage Therapeutics (SAGE) United States $2.233B 0.00
Pacira BioSciences (PCRX) United States $2.206B 45.15
Cronos Group (CRON) Canada $2.152B 61.70
Corcept Therapeutics (CORT) United States $1.969B 19.52
Xencor (XNCR) United States $1.871B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.752B 0.00
USANA Health Sciences (USNA) United States $1.729B 17.74
Akebia Therapeutics (AKBA) United States $1.704B 0.00
Indivior (INVVY) United States $1.679B 20.84
Zogenix (ZGNX) United States $1.615B 0.00
Karyopharm Therapeutics (KPTI) United States $1.441B 0.00
Portola Pharmaceuticals (PTLA) United States $1.415B 0.00
Heron Therapeutics (HRTX) United States $1.408B 0.00
Esperion Therapeutics (ESPR) United States $1.407B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.353B 14.58
Theravance Biopharma (TBPH) Cayman Islands $1.295B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.250B 0.00
Translate Bio (TBIO) United States $1.124B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.999B 44.59
BioCryst Pharmaceuticals (BCRX) United States $0.886B 0.00
Tilray (TLRY) Canada $0.869B 0.00
ImmunoGen (IMGN) United States $0.851B 0.00
Endo (ENDP) Ireland $0.802B 1.24
Radius Health (RDUS) United States $0.657B 0.00
Trillium Therapeutics (TRIL) Canada $0.657B 0.00
Aerie Pharmaceuticals (AERI) United States $0.649B 0.00
Ardelyx (ARDX) United States $0.624B 0.00
Molecular Templates (MTEM) United States $0.618B 0.00
Collegium Pharmaceutical (COLL) United States $0.600B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.576B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.556B 0.00
VAXART, INC (VXRT) United States $0.547B 0.00
Flexion Therapeutics (FLXN) United States $0.511B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.497B 12.02
Siga Technologies (SIGA) United States $0.484B 0.00
Innate Pharma SA (IPHYF) France $0.476B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.458B 17.89
DURECT (DRRX) United States $0.439B 0.00
Ocular Therapeutix (OCUL) United States $0.426B 0.00
Harpoon Therapeutics (HARP) United States $0.415B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.399B 0.00
Organogenesis Holdings (ORGO) United States $0.395B 0.00
TherapeuticsMD (TXMD) United States $0.378B 0.00
MEI Pharma (MEIP) United States $0.370B 0.00
Calithera Biosciences (CALA) United States $0.363B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.322B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.298B 0.00
OptiNose (OPTN) United States $0.296B 0.00
Lannett Co Inc (LCI) United States $0.287B 6.30
PROFOUND MEDICL (PROF) Canada $0.281B 0.00
Concert Pharmaceuticals (CNCE) United States $0.275B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.250B 0.00
CASI Pharmaceuticals (CASI) United States $0.245B 0.00
Redhill Biopharma (RDHL) Israel $0.239B 0.00
KalVista Pharmaceuticals (KALV) United States $0.231B 0.00
Jounce Therapeutics (JNCE) United States $0.222B 5.29
Rafael Holdings (RFL) United States $0.222B 0.00
Taiwan Liposome (TLC) Taiwan $0.215B 0.00
Nivalis Therapeutics (ALPN) United States $0.189B 0.00
Nature's Sunshine Products (NATR) United States $0.177B 23.33
IMV INC (IMV) Canada $0.176B 0.00
Altimmune (ALT) United States $0.162B 0.00
Aquestive Therapeutics (AQST) United States $0.158B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.152B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.147B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.120B 0.00
Champions Oncology (CSBR) United States $0.117B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.110B 0.00
Recro Pharma (REPH) United States $0.108B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.106B 0.00
Xeris Pharmaceuticals (XERS) United States $0.105B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.102B 0.00
Onconova Therapeutics (ONTX) United States $0.098B 0.00
Otonomy (OTIC) United States $0.098B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.096B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.095B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.092B 0.00
MediWound (MDWD) Israel $0.092B 0.00
CTI BioPharma (CTIC) United States $0.087B 0.00
Sundial Growers (SNDL) Canada $0.084B 0.00
Biomerica (BMRA) United States $0.083B 0.00
Hemispherx BioPharma (AIM) United States $0.079B 0.00
Heat Biologics (HTBX) United States $0.074B 0.00
SCYNEXIS (SCYX) United States $0.071B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.067B 0.00
Aclaris Therapeutics (ACRS) United States $0.063B 0.00
Lipocine (LPCN) United States $0.063B 0.00
CV Sciences (CVSI) United States $0.060B 0.00
RENEURON GP (RNUGF) United Kingdom $0.057B 0.00
Addex Therapeutics (ADXN) Switzerland $0.052B 0.00
Infinity Pharmaceuticals (INFI) United States $0.051B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 29.45
PolarityTE (PTE) United States $0.048B 0.00
Natural Alternatives (NAII) United States $0.047B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.043B 0.00
GTx (ONCT) United States $0.042B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.042B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
Mannatechorporated (MTEX) United States $0.041B 7.71
Adamis Pharmaceuticals (ADMP) United States $0.040B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.039B 83.00
Novan (NOVN) United States $0.039B 0.00
IsoRay (ISR) United States $0.038B 0.00
Neos Therapeutics (NEOS) United States $0.034B 0.00
AgeX Therapeutics (AGE) United States $0.033B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.031B 0.00
ElectroCore (ECOR) United States $0.031B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.028B 0.00
Jaguar Animal Health (JAGX) United States $0.028B 0.00
India Globalization Capital (IGC) United States $0.022B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.022B 0.00
Iterum Therapeutics (ITRM) Ireland $0.021B 0.00
Flex Pharma (SLRX) United States $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.018B 0.00
Can-Fite Biopharma (CANF) Israel $0.017B 0.00
ProPhase Labs (PRPH) United States $0.016B 0.00
China SXT Pharmaceuticals (SXTC) China $0.015B 0.00
Regulus Therapeutics (RGLS) United States $0.015B 0.00
Shineco (TYHT) China $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 33.86
Sonoma Pharmaceuticals (SNOA) United States $0.012B 0.00
RXi Pharmaceuticals (PHIO) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.010B 0.00
Vical (BBI) United States $0.010B 0.00
Midatech Pharma (MTP) United Kingdom $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00